Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms. Obstet Gynecol. 2004 Feb; 103(2):267-73.
View in:
PubMed
subject areas
Administration, Oral
Aged
Analysis of Variance
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Drug Combinations
Estrogens, Conjugated (USP)
Female
Follow-Up Studies
Hot Flashes
Humans
Middle Aged
Postmenopause
Probability
Progestins
Reference Values
Risk Assessment
Severity of Illness Index
Single-Blind Method
Treatment Outcome
Vasomotor System
authors with profiles
Brian William Walsh, M.D.